Clinical relevance of complement-fixing antibodies in cardiac transplantation

Human Immunology

Volumn 70, Issue 8, 2009, Pages 605-609

  Rose, Marlene L ^a   Smith, John D ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Alloantibodies; Cardiac transplantation; Complement; HLA antibodies; Non HLA antibodies

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN SUBCLASS;

ADULT; ALLOGRAFT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DISEASE; HEART TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; COMPLEMENT ACTIVATION; COMPLEMENT C4; CYTOTOXICITY TESTS, IMMUNOLOGIC; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN M; IMMUNOSORBENT TECHNIQUES; ISOANTIBODIES; MICROSPHERES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 68049142123     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.04.016     Document Type: Article

References (42)

1. Smith J.D., Danskine A.J., Laylor R.M., Rose M.L., and Yacoub M.H. The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transpl Immunol 1 (1993) 60-65
2. Patel R., and Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280 (1969) 735-739
3. Smith J.D., Hamour I.M., Banner N.R., and Rose M.L. C4d fixing, Luminex binding antibodies-a new tool for prediction of graft failure after heart transplantation. Am J Transplant 7 (2007) 2809-2815
4. Bielmann D., Honger G., Lutz D., Mihatsch M.J., Steiger J., and Schaub S. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 7 (2007) 626-632
5. Wahrmann M., Exner M., Regele H., Derfler K., Kormoczi G.F., Lhotta K., et al. Flow cytometry based detection of HLA alloantibody mediated classical complement activation. J Immunol Methods 275 (2003) 149-160
6. Baldwin III W.M., Pruitt S.K., Brauer R.B., Daha M.R., and Sanfilippo F. Complement in organ transplantation. Contributions to inflammation, injury, and rejection. Transplantation 59 (1995) 797-808
7. Baldwin III W.M., Qian Z., Wasowska B., and Sanfilippo F. Complement causes allograft injury by cell activation rather than lysis. Transplantation 67 (1999) 1498-1499
8. Bohmig G.A., Exner M., Habicht A., Schillinger M., Lang U., Kletzmayr J., et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 13 (2002) 1091-1099
9. Rodriguez E.R., Skojec D.V., Tan C.D., Zachary A.A., Kasper E.K., Conte J.V., et al. Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 5 (2005) 2778-2785
10. Jindra P.T., Hsueh A., Hong L., Gjertson D., Shen X.D., Gao F., et al. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol 180 (2008) 2214-2224
11. Yamakuchi M., Kirkiles-Smith N.C., Ferlito M., Cameron S.J., Bao C., Fox-Talbot K., et al. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc Natl Acad Sci USA 104 (2007) 1301-1306
12. Bartel G., Wahrmann M., Exner M., Regele H., Schillinger M., Horl W.H., et al. Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Transplantation 83 (2007) 727-733
13. Kushihata F., Watanabe J., Mulder A., Claas F., and Scornik J.C. Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential. Transplantation 78 (2004) 995-1001
14. Jurcevic S., Ainsworth M.E., Pomerance A., Smith J.D., Robinson D.R., Dunn M.J., et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 71 (2001) 886-892
15. Sumitran-Holgersson S., Wilczek H.E., Holgersson J., and Soderstrom K. Identification of the nonclassical HLA molecules, MICA, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 74 (2002) 268-277
16. Dragun D., Muller D.N., Brasen J.H., Fritsche L., Nieminen-Kelha M., Dechend R., et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352 (2005) 558-569
17. Amico P., Honger G., Bielmann D., Lutz D., Garzoni D., Steiger J., et al. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies. Transplantation 85 (2008) 1557-1563
18. Smith J.D., Hamour I.M., Burke M.M., Mahesh B., Stanford R.E., Haj-Yahia S., et al. A reevaluation of the role of IgM non-HLA antibodies in cardiac transplantation. Transplantation 87 (2009) 864-871
19. Khan N., Robson A.J., Worthington J.E., and Martin S. The detection and definition of IgM alloantibodies in the presence of IgM autoantibodies using flow PRA beads. Hum Immunol 64 (2003) 593-599
20. Taylor C.J., Chapman J.R., Ting A., and Morris P.J. Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome. Transplantation 48 (1989) 953-958
21. Kerman R.H., Kimball P., Scheinen S., Radovancevic B., van Buren C.T., Kahan B.D., et al. The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients. Transplantation 57 (1994) 884-888
22. Warraich R.S., Pomerance A., Stanley A., Banner N.R., Dunn M.J., and Yacoub M.H. Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy. Transplantation 69 (2000) 1609-1617
23. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
24. Fleming S.D. Natural antibodies, autoantibodies and complement activation in tissue injury. Autoimmunity 39 (2006) 379-386
25. Zhang M., Michael L.H., Grosjean S.A., Kelly R.A., Carroll M.C., and Entman M.L. The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 41 (2006) 62-67
26. Williams J.P., Pechet T.T., Weiser M.R., Reid R., Kobzik L., Moore Jr. F.D., et al. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 86 (1999) 938-942
27. Fleming S.D., Egan R.P., Chai C., Girardi G., Holers V.M., Salmon J., et al. Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J Immunol 173 (2004) 7055-7061
28. Fleming S.D., Monestier M., and Tsokos G.C. Accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. J Immunol 173 (2004) 4230-4235
29. Keith M.P., Moratz C., Egan R., Zacharia A., Greidinger E.L., Hoffman R.W., et al. Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1(-/-) mice. Autoimmunity 40 (2007) 208-216
30. Zhang M., Alicot E.M., Chiu I., Li J., Verna N., Vorup-Jensen T., et al. Identification of the target self-antigens in reperfusion injury. J Exp Med 203 (2006) 141-152
31. Leo A., Kreft H., Hack H., Kempf T., and Roelcke D. Restriction in the repertoire of the immunoglobulin light chain subgroup in pathological cold agglutinins with anti-Pr specificity. Vox Sang 86 (2004) 141-147
32. Krijnen P.A., Ciurana C., Cramer T., Hazes T., Meijer C.J., Visser C.A., et al. IgM colocalises with complement and C reactive protein in infarcted human myocardium. J Clin Pathol 58 (2005) 382-388
33. Moisan E., and Girard D. Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J Leukocyte Biol 79 (2006) 489-498
34. Podor T.J., Singh D., Chindemi P., Foulon D.M., McKelvie R., Weitz J.I., et al. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface. J Biol Chem 277 (2002) 7529-7539
35. Casciola-Rosen L.A., Anhalt G., and Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179 (1994) 1317-1330
36. Rosen A., and Casciola-Rosen L.A. Autoantigen as substrates for apoptopic proteases: implications for the pathogenesis of systemic autoimmune diseases. Cell Death Diff 6 (1999) 6-12
37. Baldwin III W.M., Qian Z., Ota H., Samaniego M., Wasowska B., Sanfilippo F., et al. Complement as a mediator of vascular inflammation and activation in allografts. J Heart Lung Transplant 19 (2000) 723-730
38. Miyatake T., Sato K., Takigami K., Koyamada N., Hancock W.W., Bazin H., et al. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. J Immunol 160 (1998) 4114-4123
39. Wasowska B.A., Qian Z., Cangello D.L., Behrens E., Van Tran K., Layton J., et al. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation 71 (2001) 727-736
40. Foreman K.E., Vaporciyan A.A., Bonish B.K., Jones M.L., Johnson K.J., Glovsky M.M., et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94 (1994) 1147-1155
41. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Aurora P., Christie J., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
42. Aharinejad S., Schafer R., Krenn K., Zuckermann A., Schneider B., Neumann F., et al. Donor myocardial HIF-1alpha is an independent predictor of cardiac allograft dysfunction: a 7-year prospective, exploratory study. Am J Transplant 7 (2007) 2012-2019